Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

Go back to Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
(NASDAQ: CADL) Delayed: 9.34 +0.07 (0.76%)
Previous Close $9.27    52 Week High
Open $9.24    52 Week Low
Day High $9.61    P/E N/A 
Day Low $9.06    EPS
Volume 735,898